Studies suggest GLP-1 drugs like Semaglutide and Tirzepatide may help reduce cravings for alcohol, opioids, and nicotine. Researchers say these medications influence the brain's reward system, potentially lowering addiction risk and offering a new approach to treating substance use disorder.